Switch theme
Sign up to access all valuation multiples
Jinhai Medical Technology Ltd is an investment holding company. Along with its subsidiaries, it is principally engaged in providing medical equipment in China and manpower outsourcing and ancillary services to building and construction contractors in Singapore. The group also provides IT services, construction ancillary services (which comprise warehousing, cleaning, and building maintenance works), and dormitory services in Singapore. It generates maximum revenue from the sale of minimally invasive surgery solutions, medical products, and related services in the People's Republic of China.
2017
488
Last FY Revenue $6.4M
Last FY EBITDA -$1.6M
$884M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Jinhai Medical Technology achieved revenue of $6.4M and an EBITDA of -$1.6M.
Jinhai Medical Technology expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Jinhai Medical Technology valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $6.4M | XXX | XXX | XXX |
| Gross Profit | XXX | $1.5M | XXX | XXX | XXX |
| Gross Margin | XXX | 23% | XXX | XXX | XXX |
| EBITDA | XXX | -$1.6M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -25% | XXX | XXX | XXX |
| EBIT | XXX | -$2.6M | XXX | XXX | XXX |
| EBIT Margin | XXX | -40% | XXX | XXX | XXX |
| Net Profit | XXX | -$2.3M | XXX | XXX | XXX |
| Net Margin | XXX | -36% | XXX | XXX | XXX |
| Net Debt | XXX | $45K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Jinhai Medical Technology's stock price is HKD 1 (or $0).
Jinhai Medical Technology has current market cap of HKD 6.9B (or $884M), and EV of HKD 6.9B (or $884M).
See Jinhai Medical Technology trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $884M | $884M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Jinhai Medical Technology has market cap of $884M and EV of $884M.
Jinhai Medical Technology's trades at 137.8x EV/Revenue multiple, and -556.9x EV/EBITDA.
Equity research analysts estimate Jinhai Medical Technology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Jinhai Medical Technology's P/E ratio is not available.
See valuation multiples for Jinhai Medical Technology and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $884M | XXX | $884M | XXX | XXX | XXX |
| EV (current) | $884M | XXX | $884M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 137.8x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -556.9x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -346.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -385.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -1624.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialJinhai Medical Technology's revenue per employee in the last FY averaged $13K, while opex per employee averaged $8K for the same period.
Jinhai Medical Technology's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Jinhai Medical Technology's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Jinhai Medical Technology and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -25% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $13K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $8K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 63% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Brunel International | XXX | XXX | XXX | XXX | XXX | XXX |
| Randstad | XXX | XXX | XXX | XXX | XXX | XXX |
| Mastech Digital | XXX | XXX | XXX | XXX | XXX | XXX |
| Freelancer | XXX | XXX | XXX | XXX | XXX | XXX |
| McMillan Shakespeare | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Jinhai Medical Technology acquired XXX companies to date.
Last acquisition by Jinhai Medical Technology was XXXXXXXX, XXXXX XXXXX XXXXXX . Jinhai Medical Technology acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Jinhai Medical Technology founded? | Jinhai Medical Technology was founded in 2017. |
| Where is Jinhai Medical Technology headquartered? | Jinhai Medical Technology is headquartered in Hong Kong. |
| How many employees does Jinhai Medical Technology have? | As of today, Jinhai Medical Technology has 488 employees. |
| Is Jinhai Medical Technology publicy listed? | Yes, Jinhai Medical Technology is a public company listed on HKG. |
| What is the stock symbol of Jinhai Medical Technology? | Jinhai Medical Technology trades under 02225 ticker. |
| When did Jinhai Medical Technology go public? | Jinhai Medical Technology went public in 2017. |
| Who are competitors of Jinhai Medical Technology? | Similar companies to Jinhai Medical Technology include e.g. Brunel International, Randstad, Mastech Digital, Freelancer. |
| What is the current market cap of Jinhai Medical Technology? | Jinhai Medical Technology's current market cap is $884M |
| Is Jinhai Medical Technology profitable? | Yes, Jinhai Medical Technology is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
